language-icon Old Web
English
Sign In
Acemap > Paper > 抗悪性腫瘍薬ヒト型抗ヒトCTLA-4モノクローナル抗体イピリムマブ（ヤーボイ®点滴静注液50 mg）の薬理学的特性と臨床効果

抗悪性腫瘍薬ヒト型抗ヒトCTLA-4モノクローナル抗体イピリムマブ（ヤーボイ®点滴静注液50 mg）の薬理学的特性と臨床効果

2016 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.